393 related articles for article (PubMed ID: 25774345)
21. Novel biomarkers in the diagnosis of acute coronary syndromes: the role of circulating miRNAs.
Rognoni A; Cavallino C; Lupi A; Secco GG; Veia A; Bacchini S; Rosso R; Rametta F; Bongo AS
Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1119-24. PubMed ID: 25160996
[TBL] [Abstract][Full Text] [Related]
22. Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease.
DU Y; Yang SH; Li S; Cui CJ; Zhang Y; Zhu CG; Guo YL; Wu NQ; Gao Y; Sun J; Dong Q; Liu G; Li JJ
Biomed Environ Sci; 2016 Aug; 29(8):545-554. PubMed ID: 27660218
[TBL] [Abstract][Full Text] [Related]
23. Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular disease patients.
Chang TY; Tsai WC; Huang TS; Su SH; Chang CY; Ma HY; Wu CH; Yang CY; Lin CH; Huang PH; Cheng CC; Cheng SM; Wang HW
PLoS One; 2017; 12(7):e0181562. PubMed ID: 28727754
[TBL] [Abstract][Full Text] [Related]
24. Plasma miR-10a: A Potential Biomarker for Coronary Artery Disease.
Luo L; Chen B; Li S; Wei X; Liu T; Huang Y; Lin X
Dis Markers; 2016; 2016():3841927. PubMed ID: 27313333
[TBL] [Abstract][Full Text] [Related]
25. miRNome in myocardial infarction: Future directions and perspective.
Boštjančič E; Glavač D
World J Cardiol; 2014 Sep; 6(9):939-58. PubMed ID: 25276296
[TBL] [Abstract][Full Text] [Related]
26. The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment.
Gholamin S; Pasdar A; Khorrami MS; Mirzaei H; Mirzaei HR; Salehi R; Ferns GA; Ghayour-Mobarhan M; Avan A
Curr Pharm Des; 2016; 22(3):397-403. PubMed ID: 26561061
[TBL] [Abstract][Full Text] [Related]
27. Exploring Cardiac Exosomal RNAs of Acute Myocardial Infarction.
Jung SE; Kim SW; Choi JW
Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38398032
[TBL] [Abstract][Full Text] [Related]
28. miR-941 as a promising biomarker for acute coronary syndrome.
Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
[TBL] [Abstract][Full Text] [Related]
29. Association Between Coronary Artery Disease and MicroRNA: Literature Review and Clinical Perspective.
Malik R; Mushtaque RS; Siddiqui UA; Younus A; Aziz MA; Humayun C; Mansoor K; Latif MA; Waheed S; Assad S; Khan I; Bukhari SM; DelCampo D; Adus A; Gannarapu S
Cureus; 2017 Apr; 9(4):e1188. PubMed ID: 28540143
[TBL] [Abstract][Full Text] [Related]
30. Altered Plasma miR-144 as a Novel Biomarker for Coronary Artery Disease.
Chen B; Luo L; Wei X; Gong D; Jin L
Ann Clin Lab Sci; 2018 Jul; 48(4):440-445. PubMed ID: 30143484
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA sequencing in patients with coronary artery disease - considerations for use as biomarker for thrombotic risk.
Onuoha CP; Ipe J; Simpson E; Liu Y; Skaar TC; Kreutz RP
Clin Transl Sci; 2022 Aug; 15(8):1946-1958. PubMed ID: 35643946
[TBL] [Abstract][Full Text] [Related]
32. [microRNA and internal medicine: from pathophysiology to the new diagnostic and therapeutic procedures].
Novak J; Souček M
Vnitr Lek; 2016; 62(6):477-85. PubMed ID: 27485847
[TBL] [Abstract][Full Text] [Related]
33. MiRroring the Multiple Potentials of MicroRNAs in Acute Myocardial Infarction.
Paiva S; Agbulut O
Front Cardiovasc Med; 2017; 4():73. PubMed ID: 29209617
[TBL] [Abstract][Full Text] [Related]
34. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
[TBL] [Abstract][Full Text] [Related]
35. microRNAs: Promising Biomarkers and Therapeutic Targets of Acute Myocardial Ischemia.
Fasanaro P; D'Alessandra Y; Magenta A; Pompilio G; Capogrossi MC
Curr Vasc Pharmacol; 2015; 13(3):305-15. PubMed ID: 23713865
[TBL] [Abstract][Full Text] [Related]
36. Association of Circulating microRNAs with Coronary Artery Disease and Usefulness for Reclassification of Healthy Individuals: The REGICOR Study.
Dégano IR; Camps-Vilaró A; Subirana I; García-Mateo N; Cidad P; Muñoz-Aguayo D; Puigdecanet E; Nonell L; Vila J; Crepaldi FM; de Gonzalo-Calvo D; Llorente-Cortés V; Pérez-García MT; Elosua R; Fitó M; Marrugat J
J Clin Med; 2020 May; 9(5):. PubMed ID: 32397522
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs in Coronary Heart Disease: Ready to Enter the Clinical Arena?
Cavarretta E; Frati G
Biomed Res Int; 2016; 2016():2150763. PubMed ID: 27882321
[TBL] [Abstract][Full Text] [Related]
38. Circulating microRNA-378 levels serve as a novel biomarker for assessing the severity of coronary stenosis in patients with coronary artery disease.
Li H; Gao F; Wang X; Wu J; Lu K; Liu M; Li R; Ding L; Wang R
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31064817
[No Abstract] [Full Text] [Related]
39. Free Circulating miRNAs Measurement in Clinical Settings: The Still Unsolved Issue of the Normalization.
Faraldi M; Gomarasca M; Banfi G; Lombardi G
Adv Clin Chem; 2018; 87():113-139. PubMed ID: 30342709
[TBL] [Abstract][Full Text] [Related]
40. Circulating miRNA-33: a potential biomarker in patients with coronary artery disease.
Reddy LL; Shah SAV; Ponde CK; Rajani RM; Ashavaid TF
Biomarkers; 2019 Feb; 24(1):36-42. PubMed ID: 30022694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
